Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
RRE Ventures GP II, LLC
  2. Issuer Name and Ticker or Trading Symbol
VOCERA COMMUNICATIONS, INC. [VCRA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
130 EAST 59TH STREET, 17TH FLOOR
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2012
(Street)

NEW YORK, NY 10022
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/02/2012   C   314,759 A (1) 314,759 I by RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   55,062 A (1) 55,062 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012   C   393,406 A (4) 708,165 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   68,820 A (4) 123,882 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012   C   754,133 A (1) 1,462,298 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   131,831 A (1) 255,713 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012   C   285,577 A (1) 1,747,875 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   49,922 A (1) 305,635 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012   C   78,738 A (1) 1,826,613 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   13,768 A (1) 319,403 I By RRE Ventures Fund II, L.P. (3)
Common Stock 04/02/2012   C   57,005 A (1) 1,883,618 I By RRE Ventures II, L.P. (2)
Common Stock 04/02/2012   C   9,972 A (1) 329,375 I By RRE Ventures Fund II, L.P. (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock (1) 04/02/2012   C     314,759   (1)   (1) Common Stock 314,759 (1) 0 I By RRE Ventures II, L.P. (2)
Series A Convertible Preferred Stock (1) 04/02/2012   C     55,062   (1)   (1) Common Stock 55,062 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series B Convertible Preferred Stock (4) 04/02/2012   C     214,927   (4)   (4) Common Stock 393,406 (4) 0 I By RRE Ventures II, L.P. (2)
Series B Convertible Preferred Stock (4) 04/02/2012   C     37,598   (4)   (4) Common Stock 68,820 (4) 0 I By RRE Ventures Fund II, L.P. (3)
Series C Convertible Preferred Stock (1) 04/02/2012   C     754,133   (1)   (1) Common Stock 754,133 (1) 0 I By RRE Ventures II, L.P. (2)
Series C Convertible Preferred Stock (1) 04/02/2012   C     131,831   (1)   (1) Common Stock 131,831 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series D Convertible Preferred Stock (1) 04/02/2012   C     285,577   (1)   (1) Common Stock 285,577 (1) 0 I By RRE Ventures II, L.P. (2)
Series D Convertible Preferred Stock (1) 04/02/2012   C     49,922   (1)   (1) Common Stock 49,922 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series E Convertible Preferred Stock (1) 04/02/2012   C     78,738   (1)   (1) Common Stock 78,738 (1) 0 I By RRE Ventures II, L.P. (2)
Series E Convertible Preferred Stock (1) 04/02/2012   C     13,768   (1)   (1) Common Stock 13,768 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series F Convertible Preferred Stock (1) 04/02/2012   C     57,005   (1)   (1) Common Stock 57,005 (1) 0 I By RRE Ventures II, L.P. (2)
Series F Convertible Preferred Stock (1) 04/02/2012   C     9,972   (1)   (1) Common Stock 9,972 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Series E Convertible Pref St Purchase Warrant (Right to Buy) $ 6.61 04/02/2012   C     23,621   (5) 10/19/2015 Series E Convertible Preferred Stock (1) 23,621 (1) 0 I By RRE Ventures II, L.P. (2)
Common Stock Purchase Warrant (Right to Buy) $ 6.61 04/02/2012   C   23,621     (5) 10/19/2015 Common Stock 23,621 (1) 23,621 I By RRE Ventures II, L.P. (2)
Series E Convertible Pref St Purchase Warrant (Right to Buy) $ 6.61 04/02/2012   C     4,130   (5) 10/19/2015 Series E Convertible Preferred Stock (1) 4,130 (1) 0 I By RRE Ventures Fund II, L.P. (3)
Common Stock Purchase Warrant (Right to Buy) $ 6.61 04/02/2012   C   4,130     (5) 10/19/2015 Common Stock 4,130 (1) 4,130 I By RRE Ventures Fund II, L.P. (3)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
RRE Ventures GP II, LLC
130 EAST 59TH STREET
17TH FLOOR
NEW YORK, NY 10022
    X    
RRE Ventures II, LP
130 EAST 59TH STREET
17TH FLOOR
NEW YORK, NY 10022
    X    
RRE Ventures Fund II, LP
130 EAST 59TH STREET
17TH FLOOR
NEW YORK, NY 10022
    X    

Signatures

 /s/ Andrew Zalasin, Member   04/04/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Each share of Series A, Series C, Series D, Series E and Series F Convertible Preferred Stock converted into one share of common stock upon the completion of the Issuer's initial public offering and had no expiration date.
(2) RRE Ventures GP II, LLC ("RRE GP") is the sole general partner of RRE Ventures II, L.P. James D. Robinson III, James D. Robinson IV, Stuart J. Ellman, and Andrew L. Zalasin are members of RRE GP and may be deemed to have shared voting and investment control with respect to these shares. Each of RRE GP and Messrs. Robinson III, Robinson IV, Ellman, and Zalasin disclaim beneficial ownership of these shares except to the extent of its or his pecuniary interest therein.
(3) RRE GP is the sole general partner of RRE Ventures Fund II, L.P. James D. Robinson III, James D. Robinson IV, Stuart J. Ellman, and Andrew L. Zalasin are members of RRE GP and may be deemed to have shared voting and investment control with respect to these shares. Each of RRE GP and Messrs. Messrs. Robinson III, Robinson IV, Ellman, and Zalasin disclaim beneficial ownership of these shares except to the extent of its or his pecuniary interest therein.
(4) Each share of Series B Convertible Preferred Stock converted into 1.8304174 shares of common stock upon the completion of the Issuer's initial public offering and had no expiration date.
(5) Immediately exercisable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.